Becton, Dickinson and Company (LON:0R19)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 41.39B |
| Revenue (ttm) | 15.61B |
| Net Income (ttm) | 1.16B |
| Shares Out | n/a |
| EPS (ttm) | 3.99 |
| PE Ratio | 35.78 |
| Forward PE | 13.59 |
| Dividend | 3.11 (1.59%) |
| Ex-Dividend Date | Jun 9, 2025 |
| Volume | 810 |
| Average Volume | 1,736 |
| Open | 195.21 |
| Previous Close | 192.78 |
| Day's Range | 193.94 - 196.12 |
| 52-Week Range | 163.64 - 251.08 |
| Beta | 0.22 |
| RSI | 67.86 |
| Earnings Date | Aug 7, 2025 |
About DFS
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]
Financial Performance
In 2024, LON:0R19's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.
Financial numbers in GBP Financial StatementsNews
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
FRANKLIN LAKES, N.J. , July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination produ...
BD Board Declares Dividend
FRANKLIN LAKES, N.J. , July 22, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decla...
Best Dividend Kings: July 2025
14 Dividend Kings continue to outperform the S&P 500 in 2025. Dividend growth remains healthy, with one recent increase and a collective 2025 growth rate of 5.23%. Seventeen Dividend Kings currently a...
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio ? Elevance Health, Inc. (NYSE: ELV) shares decreased 17.96% this week after the company lowered its f...
WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger o...
How Do Investors Really Feel About Becton Dickinson?
Becton Dickinson's (NYSE: BDX) short percent of float has risen 21.62% since its last report. The company recently reported that it has 3.90 million shares sold short , which is 1.35% of all regular ...
Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks
Waters downgraded at Wells Fargo after Becton, Dickinson deal
Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business
A Big Move By Waters Corporation And Becton, Dickinson And Company
Waters to buy Becton Dickinson unit in a $17.5 billion deal amid tariff pressures
Waters Corp will buy a unit spun off from medtech provider Becton Dickinson in a stock-and-cash transaction valued at $17.5 billion, the companies said.
Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal
Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 billion.
Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit
Becton Dickinson gets its spinoff deal, but the stock is still falling
Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
FRANKLIN LAKES, N.J. , July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin ha...
Best Dividend Aristocrats For July 2025
Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising pa...
New vaccine panel meeting underway
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on vaccines.
Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now
Shares of Becton Dickinson and Company (NYSE: BDX) are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasti...
Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now
Shares of Becton Dickinson and Company BDX are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting until ...
Best Dividend Kings: June 2025
Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a c...
New Jersey Rep. Thomas Kean Bought Over $4K Worth of Amazon.com Stock: Here's What You Should Know
An official report on June 17, 2025 reveals Representative Thomas Kean's recent purchase of Amazon.com (NASDAQ: AMZN) stock, valued between $4,004 and $60,000. The transaction took place on May 8, 20...
Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
Becton, Dickinson: A Dividend King Facing Challenges Offers Value
June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss
Despite bubble fears, 91% of market gains since 2009 are justified by fundamentals like earnings, dividends, and strong balance sheets. Stocks appear overvalued at face value, but strong long-term ear...